Blueprint Medicines shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Blueprint Medicines by Balyasny Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $480k | 5.2k | 92.24 |
2022-12-31 | $41k | 941 | 43.81 |
2021-12-31 | $4.5M | 42k | 107.10 |
2021-09-30 | $2.8M | 28k | 102.83 |
2021-06-30 | $10M | 115k | 87.96 |
2020-12-31 | $14M | 126k | 112.15 |
2020-03-31 | $4.5M | 76k | 58.48 |
2018-09-30 | $452k | 5.8k | 78.13 |
2018-03-31 | $21M | 228k | 91.70 |
2017-12-31 | $3.3M | 44k | 75.40 |
2017-09-30 | $6.3M | 90k | 69.67 |